Ablexis reveals license agreement with Adimab
Ablexis, LLC, One of the biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, recently announced a license agreement with Adimab, LLC (“Adimab”). The non-exclusive license grants Adimab rights to implement select strains of AlivaMab Mouse into its proprietary yeast-based technology for antibody drug discovery for its clients. Financial terms of […]
